Use of dialysis, tracheostomy, and extracorporeal membrane oxygenation among 240,392 patients hospitalized with COVID-19 in the United States
By
Edward Burn,
Anthony G. Sena,
Albert Prats-Uribe,
Matthew Spotnitz,
Scott DuVall,
Kristine E Lynch,
Michael E Matheny,
Fredrik Nyberg,
Waheed-Ul-Rahman Ahmed,
Osaid Alser,
Heba AlGhoul,
Thamir Alshammari,
Lin Zhang,
Paula Casajust,
Carlos Areia,
Karishma Shah,
Christian Reich,
Clair Blacketer,
Alan Andryc,
Stephen Fortin,
Karthik Natarajan,
Mengchun Gong,
Asieh Golozar,
Daniel Morales,
Peter Rijnbeek,
Vignesh Subbian,
Elena Roel,
Martina Recalde,
Jennifer C.E. Lane,
David Vizcaya,
Jose D. Posada,
Nigam H Shah,
Jitendra Jonnagaddala,
Lana Yin Hui Lai,
Francesc Xavier Aviles-Jurado,
George Hripcsak,
Marc A. Suchard,
Otavio T. Ranzani,
Patrick Ryan,
Daniel Prieto-Alhambra,
Kristin Kostka,
Talita Duarte-Salles
Posted 27 Nov 2020
medRxiv DOI: 10.1101/2020.11.25.20229088
Objective To estimate the proportion of patients hospitalized with COVID-19 who undergo dialysis, tracheostomy, and extracorporeal membrane oxygenation (ECMO). Design A network cohort study. Setting Six databases from the United States containing routinely-collected patient data: HealthVerity, Premier, IQVIA Open Claims, Optum EHR, Optum SES, and VA-OMOP. Patients Patients hospitalized with a clinical diagnosis or a positive test result for COVID-19. Interventions Dialysis, tracheostomy, and ECMO. Measurements and Main Results 240,392 patients hospitalized with COVID-19 were included (22,887 from HealthVerity, 139,971 from IQVIA Open Claims, 29,061 from Optum EHR, 4,336 from OPTUM SES, 36,019 from Premier, and 8,118 from VA-OMOP). Across the six databases, 9,703 (4.04% [95% CI: 3.96% to 4.11%]) patients received dialysis, 1,681 (0.70% [0.67% to 0.73%]) had a tracheostomy, and 398 (0.17% [95% CI: 0.15% to 0.18%]) patients underwent ECMO over the 30 days following hospitalization. Use of ECMO was generally concentrated among patients who were younger, male, and with fewer comorbidities except for obesity. Tracheostomy was used for a similar proportion of patients regardless of age, sex, or comorbidity. While dialysis was used for a similar proportion among younger and older patients, it was more frequent among male patients and among those with chronic kidney disease. Conclusion Use of dialysis among those hospitalized with COVID-19 is high at around 4%. Although less than one percent of patients undergo tracheostomy and ECMO, the absolute numbers of patients who have undergone these interventions is substantial and can be expected to continue grow given the continuing spread of the COVID-19.
Download data
- Downloaded 1,137 times
- Download rankings, all-time:
- Site-wide: 32,794
- In infectious diseases: 3,007
- Year to date:
- Site-wide: 26,565
- Since beginning of last month:
- Site-wide: 58,708
Altmetric data
Downloads over time
Distribution of downloads per paper, site-wide
PanLingua
News
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!